(Q35774112)

10 August 2017

1 reference

title

Extended-release formulations: simplifying strategies in the management of antiepileptic drug therapy (English)

1 reference

10 August 2017

John M Pellock

1

1 reference

10 August 2017

Michael C Smith

2

1 reference

10 August 2017

James C Cloyd

3

1 reference

10 August 2017

Basim Uthman

4

1 reference

10 August 2017

B J Wilder

5

1 reference

10 August 2017

language of work or name

1 reference

1 June 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

5

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

301-307

1 reference

Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Early identification of refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

The relationship between poor medication compliance and seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Standard approach to antiepileptic drug treatment in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Standard approach to antiepileptic drug treatment in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Antiepileptic drug pharmacokinetics and interactions: impact on treatment of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Correlation between daily fluctuations of carbamazepine serum levels and intermittent side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Seizure Activity and Anticonvulsant Drug Concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Bioavailability of a Divalproex Extended-Release Formulation versus the Conventional Divalproex Formulation in Adult Patients Receiving Enzyme-Inducing Antiepileptic Drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Divalproex-ER pharmacokinetics in older children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Comparative bioavailability and steady state fluctuations of Tegretol commercial and carbamazepine OROS tablets in adult and pediatric epileptic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

7 January 2021

Reducing overtreatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Women with epilepsy. Reproduction and effects of pregnancy on epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Antiepileptic drug therapy: general treatment principles and application for special patient populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Effects of menopause on seizures in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Managing pediatric epilepsy syndromes with new antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

Management of epilepsy in adolescents and adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.01.009

10.1016/J.YEBEH.2004.01.009

7 January 2021

Identifiers

DOI

1 reference

10 August 2017

1 reference